Comparing Utility of Intraoperative Magnetic Resonance Imaging and 5-Aminolevulinic Acid in High-Grade Glioma Resection Surgery: A Systematic Review and Meta-Analysis.
Nova Kristine de Los Reyes-Nabhan, Siddharth Sinha, Imran Noorani
{"title":"Comparing Utility of Intraoperative Magnetic Resonance Imaging and 5-Aminolevulinic Acid in High-Grade Glioma Resection Surgery: A Systematic Review and Meta-Analysis.","authors":"Nova Kristine de Los Reyes-Nabhan, Siddharth Sinha, Imran Noorani","doi":"10.1227/neuprac.0000000000000146","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>High-grade glioma has a poor prognosis despite advancements in histopathological classifications and treatments. Various intraoperative modalities are used to maximize extent of resection (EoR) and intraoperative detection of residual tumor, including 5-aminolevulinic acid (5-ALA) and intraoperative MRI (iMRI). We conducted a systematic review with meta-analysis investigating the efficacy of iMRI vs 5-ALA in maximizing EoR and improving survival outcomes.</p><p><strong>Methods: </strong>A systematic review with meta-analysis was performed using Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, PubMed, Embase, Scopus, and ClinicalTrials.gov databases, identifying randomized clinical trials (RCTs) and prospective studies comparing the use of 5-ALA and iMRI in high-grade glioma resection. The primary end points were EoR and survival outcomes. Quality assessment was conducted using the ROBINS-I risk of bias assessment and Jadad scale. Meta-analysis was performed using gross total resection rates, tumor detection sensitivity, and specificity.</p><p><strong>Results: </strong>Five RCTs and 5 prospective studies were identified. Five RCTs lacked published data, thus only 5 prospective studies were included in the data extraction. Combined 5-ALA with iMRI (100%) was superior to 5-ALA alone (61.7%; <i>P</i> < .002) in maximizing EoR. Gross total resection did not differ significantly between 5-ALA alone (78%) and iMRI alone (81%; <i>P</i> = .79). One study showed that specificity was higher with iMRI alone (0.70) than with 5-ALA alone (0.43; <i>P</i> < .001); however, this was not replicated by 2 other studies (iMRI vs 5-ALA: 0.60 vs 0.80, <i>P</i> < .001; 1.00 vs 1.00, <i>P</i> not significant). Two studies reported sensitivity; only 1 found lower sensitivity with iMRI vs 5-ALA with a significant difference (iMRI vs 5-ALA: 0.66 vs 0.90, <i>P</i> < .001).</p><p><strong>Conclusion: </strong>There is no clear evidence to suggest iMRI is superior to 5-ALA in maximizing EoR and improving survival. However, combined use of 5-ALA and iMRI may be more effective compared with either modality alone. Larger RCTs are needed to confirm any differences in efficacy between the 2 modalities.</p>","PeriodicalId":74298,"journal":{"name":"Neurosurgery practice","volume":"6 3","pages":"e000146"},"PeriodicalIF":0.6000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12560701/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgery practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1227/neuprac.0000000000000146","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: High-grade glioma has a poor prognosis despite advancements in histopathological classifications and treatments. Various intraoperative modalities are used to maximize extent of resection (EoR) and intraoperative detection of residual tumor, including 5-aminolevulinic acid (5-ALA) and intraoperative MRI (iMRI). We conducted a systematic review with meta-analysis investigating the efficacy of iMRI vs 5-ALA in maximizing EoR and improving survival outcomes.
Methods: A systematic review with meta-analysis was performed using Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, PubMed, Embase, Scopus, and ClinicalTrials.gov databases, identifying randomized clinical trials (RCTs) and prospective studies comparing the use of 5-ALA and iMRI in high-grade glioma resection. The primary end points were EoR and survival outcomes. Quality assessment was conducted using the ROBINS-I risk of bias assessment and Jadad scale. Meta-analysis was performed using gross total resection rates, tumor detection sensitivity, and specificity.
Results: Five RCTs and 5 prospective studies were identified. Five RCTs lacked published data, thus only 5 prospective studies were included in the data extraction. Combined 5-ALA with iMRI (100%) was superior to 5-ALA alone (61.7%; P < .002) in maximizing EoR. Gross total resection did not differ significantly between 5-ALA alone (78%) and iMRI alone (81%; P = .79). One study showed that specificity was higher with iMRI alone (0.70) than with 5-ALA alone (0.43; P < .001); however, this was not replicated by 2 other studies (iMRI vs 5-ALA: 0.60 vs 0.80, P < .001; 1.00 vs 1.00, P not significant). Two studies reported sensitivity; only 1 found lower sensitivity with iMRI vs 5-ALA with a significant difference (iMRI vs 5-ALA: 0.66 vs 0.90, P < .001).
Conclusion: There is no clear evidence to suggest iMRI is superior to 5-ALA in maximizing EoR and improving survival. However, combined use of 5-ALA and iMRI may be more effective compared with either modality alone. Larger RCTs are needed to confirm any differences in efficacy between the 2 modalities.
背景和目的:尽管在组织病理学分类和治疗方面取得了进展,但高级别胶质瘤的预后较差。为了最大限度地切除(EoR)和术中残余肿瘤的检测,采用了多种术中方式,包括5-氨基乙酰丙酸(5-ALA)和术中MRI (iMRI)。我们进行了一项系统综述和荟萃分析,调查了iMRI与5-ALA在提高EoR和改善生存结果方面的疗效。方法:使用系统评价和荟萃分析指南的首选报告项目、PubMed、Embase、Scopus和ClinicalTrials.gov数据库进行系统评价和荟萃分析,确定随机临床试验(rct)和前瞻性研究,比较5-ALA和iMRI在高级别胶质瘤切除术中的使用。主要终点是EoR和生存结果。采用ROBINS-I偏倚风险评估和Jadad量表进行质量评价。采用总切除率、肿瘤检测敏感性和特异性进行meta分析。结果:共纳入5项随机对照试验和5项前瞻性研究。5项rct缺乏已发表的数据,因此只有5项前瞻性研究被纳入数据提取。5-ALA联合iMRI在提高提高采收率方面(100%)优于5-ALA单独(61.7%,P < 0.002)。5-ALA单独(78%)和iMRI单独(81%,P = 0.79)的总切除没有显著差异。一项研究表明,单独使用iMRI的特异性(0.70)高于单独使用5-ALA (0.43, P < 0.001);然而,其他两项研究没有重复这一结果(iMRI vs 5-ALA: 0.60 vs 0.80, P < 0.001; 1.00 vs 1.00, P无统计学意义)。两项研究报告了敏感性;只有1例发现iMRI与5-ALA的敏感性较低,差异有统计学意义(iMRI与5-ALA: 0.66 vs 0.90, P < 0.001)。结论:没有明确的证据表明iMRI在提高EoR和提高生存率方面优于5-ALA。然而,联合使用5-ALA和iMRI可能比单独使用任何一种方式更有效。需要更大的随机对照试验来证实两种方式之间的疗效差异。